The investment seeks to track the performance of the FTSE Global All Cap ex US Choice Index... Show more
The Moving Average Convergence Divergence (MACD) for VSGX turned positive on July 01, 2025. Looking at past instances where VSGX's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 30, 2025. You may want to consider a long position or call options on VSGX as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VSGX advanced for three days, in of 341 cases, the price rose further within the following month. The odds of a continued upward trend are .
VSGX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 271 cases where VSGX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for VSGX moved out of overbought territory on June 13, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Category ForeignLargeBlend
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BCUS | 31.84 | 0.30 | +0.96% |
BANCREEK U.S. Large Cap ETF | |||
BBC | 20.32 | 0.13 | +0.65% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
TEQI | 43.13 | 0.22 | +0.51% |
T. Rowe Price Equity Income ETF | |||
EFFE | 21.87 | N/A | N/A |
Harbor Osmosis Emerging Markets Resource Efficient ETF | |||
IBDW | 20.89 | -0.05 | -0.21% |
iShares iBonds Dec 2031 Term Corp ETF |
A.I.dvisor indicates that over the last year, VSGX has been closely correlated with VXUS. These tickers have moved in lockstep 98% of the time. This A.I.-generated data suggests there is a high statistical probability that if VSGX jumps, then VXUS could also see price increases.
Ticker / NAME | Correlation To VSGX | 1D Price Change % | ||
---|---|---|---|---|
VSGX | 100% | +0.43% | ||
VXUS - VSGX | 98% Closely correlated | +0.23% | ||
VEU - VSGX | 98% Closely correlated | +0.18% | ||
VEA - VSGX | 97% Closely correlated | +0.12% | ||
IEFA - VSGX | 95% Closely correlated | +0.05% | ||
EFA - VSGX | 95% Closely correlated | +0.02% | ||
More |